Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Jensen

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|May 25, 2004
Strategies for long-term gene expression in the skin to treat metabolic disordersThomas G Jensen
Annals of Medicine|April 25, 2007
Cutaneous gene therapyThomas G Jensen
Journal of Biomedicine & Biotechnology|May 10, 2007
Nanomedicine: techniques, potentials, and ethical implicationsMette Ebbesen, Thomas G Jensen
Ugeskrift for Laeger|June 11, 2010
[Gene therapy for severe combined immunodeficiency]Line Barrett Petersen, Thomas G Jensen
Ugeskrift for Laeger|March 31, 2007
[Gene therapy. The Danish Society of Medical Genetics]Thomas G Jensen, Karen Brøndum-Nielsen,
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2009
A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs)Tina Skjørringe, Torben Gjetting, Thomas G Jensen
Molecular Genetics and Metabolism|September 5, 2002
Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuriaRikke Christensen, Flemming Güttler, Thomas G Jensen
Cells, Tissues, Organs|July 28, 2005
Manipulation of the phenylalanine metabolism in human keratinocytes by retroviral mediated gene transferRikke Christensen, Steen Kolvraa, Thomas G Jensen
Acta Dermato-Venereologica|May 9, 2003
Production of retroviral vectors in primary human keratinocytes after DNA-mediated gene transfer leads to prolonged gene expressionThomas G Jensen, Uffe B Jensen, Lars Bolund
Ugeskrift for Laeger|March 27, 2009
[Genetic variation studies a breakthrough in the understanding of many common diseases]Ditte Demontis, Thomas G Jensen, Anders D Børglum
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|May 25, 2004
Strategies for long-term gene expression in the skin to treat metabolic disordersThomas G Jensen
Annals of Medicine|April 25, 2007
Cutaneous gene therapyThomas G Jensen
Journal of Biomedicine & Biotechnology|May 10, 2007
Nanomedicine: techniques, potentials, and ethical implicationsMette Ebbesen, Thomas G Jensen
Ugeskrift for Laeger|June 11, 2010
[Gene therapy for severe combined immunodeficiency]Line Barrett Petersen, Thomas G Jensen
Ugeskrift for Laeger|March 31, 2007
[Gene therapy. The Danish Society of Medical Genetics]Thomas G Jensen, Karen Brøndum-Nielsen,
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2009
A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs)Tina Skjørringe, Torben Gjetting, Thomas G Jensen
Molecular Genetics and Metabolism|September 5, 2002
Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuriaRikke Christensen, Flemming Güttler, Thomas G Jensen
Cells, Tissues, Organs|July 28, 2005
Manipulation of the phenylalanine metabolism in human keratinocytes by retroviral mediated gene transferRikke Christensen, Steen Kolvraa, Thomas G Jensen
Acta Dermato-Venereologica|May 9, 2003
Production of retroviral vectors in primary human keratinocytes after DNA-mediated gene transfer leads to prolonged gene expressionThomas G Jensen, Uffe B Jensen, Lars Bolund
Ugeskrift for Laeger|March 27, 2009
[Genetic variation studies a breakthrough in the understanding of many common diseases]Ditte Demontis, Thomas G Jensen, Anders D Børglum
Pageof 6